Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes using monoclonal antibodies.

Archive ouverte

Fofana, Isabel | Zona, Laetitia | Thumann, Christine | Heydmann, Laura | Durand, Sarah, C. | Lupberger, Joachim | Blum, Hubert, E. | Pessaux, Patrick | Gondeau, Claire | Reynolds, Gary, M. | Mckeating, Jane, A. | Grunert, Fritz | Thompson, John | Zeisel, Mirjam, B. | Baumert, Thomas, F.

Edité par CCSD ; American Society for Microbiology -

International audience. : The relevance of claudin-6 and claudin-9 in hepatitis C virus (HCV) entry remains elusive. We produced claudin-6 or claudin-9 specific monoclonal antibodies that inhibit HCV entry into non-hepatic cells expressing exogenous claudin-6 or claudin-9. These antibodies had no effect on HCV infection of hepatoma cells or primary hepatocytes. Thus although claudin-6 and claudin-9 can serve as entry factors in cell lines, HCV infection into human hepatocytes is not dependent on claudin-6 and claudin-9.

Suggestions

Du même auteur

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.

Archive ouverte | Lupberger, Joachim | CCSD

International audience. Hepatitis C virus (HCV) is a major cause of liver disease, but therapeutic options are limited and there are no prevention strategies. Viral entry is the first step of infection and requires ...

A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission.

Archive ouverte | Fofana, Isabel | CCSD

International audience. BACKGROUND AND AIMS: Hepatitis C virus (HCV) infection is a challenge to prevent and treat because of the rapid development of drug resistance and escape. Viral entry is required for initiati...

Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.

Archive ouverte | Fofana, Isabel | CCSD

International audience. BACKGROUND & AIMS: Hepatitis C virus (HCV) infection is a challenge to prevent and treat because of the rapid development of drug resistance and escape. Viral entry is required for initiation...

Chargement des enrichissements...